Skip to main content
Caplight Logo









Portal Diabetes, Inc.

Portal Diabetes, Inc.

Private
Westfield, IndianaHealthcare & Life Scienceshttps://www.portaldiabetes.com/

Last Round

Grant

Sep 24, 2024

Total Funding Raised

$2.65M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Portal Diabetes, Inc. is a medical technology company developing a fully automated, implantable insulin pump system designed to function as an artificial pancreas for patients with type 1 diabetes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

artificial pancreasimplantable insulin pumpclosed-loop systemType 1 diabetesmedical deviceinsulin deliveryautomated insulin deliveryAID systemintraperitoneal insulinbiotechnologydiabetes techcontinuous glucose monitoringCGMFDA breakthrough devicediabetes management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Portal Diabetes, Inc. Comparables

Compare Portal Diabetes, Inc. with similar companies based on industry and business-model similarity.

Portal Diabetes, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Beta Bionics
72%
Sequel Med Tech
70%
Medtronic
70%

Portal Diabetes, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 24, 2024
VC RoundDec 5, 2019
GrantJun 1, 2017

Key People

Founding team and executive leadership

Stacy Chambliss

Chief Executive Officer

Executive Team

Ted Randolph

Chief Operating Officer

Executive Team

Portal Diabetes, Inc. Investors

Notable investors and investment history

Portal Diabetes, Inc. investors
InvestorRounds
U.S. Department of Health and Human ServicesGrant
Indiana Economic Development CorporationGrant
JDRFGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 69% MoM, reaching 1.6K.

  • Apr 8, 2026

    Grew 19% QoQ, from 27 to 32 employees.

Portal Diabetes, Inc. Filings

Explore SEC and related filing metadata, where available.

Portal Diabetes, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Portal Diabetes, Inc.'s valuation, stock price, and market status.

Is Portal Diabetes, Inc. a public or private company?

Portal Diabetes, Inc. is a private company.

What is the current stock price of Portal Diabetes, Inc.?

Portal Diabetes, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Portal Diabetes, Inc. worth (valuation)?

Valuation information for Portal Diabetes, Inc. is not publicly available.

Can I buy Portal Diabetes, Inc. stock?

Portal Diabetes, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Portal Diabetes, Inc.'s last funding round?

Portal Diabetes, Inc.'s most recent funding round was Grant on September 24, 2024.

Who are the main investors in Portal Diabetes, Inc.?

Key investors in Portal Diabetes, Inc. include U.S. Department of Health and Human Services, Indiana Economic Development Corporation, JDRF.

Will Portal Diabetes, Inc. IPO soon?

No public IPO plans have been announced for Portal Diabetes, Inc..

How can I track Portal Diabetes, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Portal Diabetes, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWestfield, Indiana
Employee Range28
Year Founded2013
Last FundingSep 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?